The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
Open accessAbstract
The clinical value of amphotericin B, the mainstay therapy for visceral leishmaniasis in sodium antimony gluconate-nonresponsive zones of Bihar, India, is now threatened by the emergence of acquired drug resistance, and a comprehensive understanding of the underlying mechanisms is the need of the hour. We have selected an amphotericin B-resistant clinical isolate which demonstrated 8-fold-higher 50% lethal doses (LD 50 ) than an amphotericin B-sensitive strain to explore the mechanism of amphotericin B resistance. Fluorimetric analysis demonstrated lower anisotropy in the motion of the diphenylhexatriene fluorescent probe in the resistant strain, which indicated a higher fluidity of the membrane for the resistant strain than for the sensitive strain. The expression patterns of the two transcripts of S -adenosyl- l -methionine:C-24-Δ-sterol methyltransferase and the absence of ergosterol, replaced by cholesta-5,7,24-trien-3β-ol in the membrane of the resistant parasite, indicate a decreased amphotericin B affinity, which is evidenced by decreased amphotericin B uptake. The expression level of MDR1 is found to be higher in the resistant strain, suggesting a higher rate of efflux of amphotericin B. The resistant parasite also possesses an upregulated tryparedoxin cascade and a more-reduced intracellular thiol level, which helps in better scavenging of reactive oxygen species produced by amphotericin B. The resistance to amphotericin B was partially reverted by the thiol metabolic pathway and ABC transporter inhibitors. Thus, it can be concluded that altered membrane composition, ATP-binding cassette transporters, and an upregulated thiol metabolic pathway have a role in conferring amphotericin B resistance in clinical isolates of Leishmania donovani .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,311
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
Prentice, T. (2013) · Res Medica · doi:10.2218/resmedica.v21i1.510 · Cited by 1,707
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
The function of sterols in membranes
Demel, R. A., & De Kruyff, B. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(76)90008-3 · Cited by 1,341
METABOLISM AND FUNCTIONS OF TRYPANOTHIONE IN THE KINETOPLASTIDA
Fairlamb, A. H., & Cerami, A. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.003403 · Cited by 768
Lentz, B. R., Barenholz, Y., & Thompson, T. E. (1976) · Biochemistry · doi:10.1021/bi00665a030 · Cited by 763
How do the polyene macrolide antibiotics affect the cellular membrane properties?
Bolard, J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(86)90002-x · Cited by 750
Fairlamb, A. H., Blackburn, P., Ulrich, P., Chait, B. T., & Cerami, A. (1985) · Science · doi:10.1126/science.3883489 · Cited by 683
Sterol, Structure and Membrane Function
Bloch, K. E. (1983) · Critical Reviews in Biochemistry · doi:10.3109/10409238309102790 · Cited by 677
Amphotericin B: current understanding of mechanisms of action
Brajtburg, J., Powderly, W. G., Kobayashi, G. S., & Medoff, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.183 · Cited by 504
Injectable Paromomycin for Visceral Leishmaniasis in India
Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.
Fojo, A. T., Akiyama, S., Gottesman, M. M., et al. (1985) · PubMed · Cited by 435
Use of fluorescent probes to monitor molecular order and motions within liposome bilayers
Lentz, B. R. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90060-g · Cited by 386
Identification of Plant Sterols Using Combined GLC/Mass Spectrometry
Knights, B. A. (1967) · Journal of Chromatographic Science · doi:10.1093/chromsci/5.6.273 · Cited by 364
Lemke, A., Kiderlen, A. F., & Kayser, O. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1955-9 · Cited by 305
Krauth‐Siegel, R. L., Bauer, H., & Schirmer, R. H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200300639 · Cited by 302
Nogoceke, E., Gommel, D. U., Kieß, M., Kalisz, H. M., & Flohé, L. (1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.8.827 · Cited by 275
Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.
Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., Ouellette, M., & Rosen, B. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10383 · Cited by 238
Glutathione and trypanothione in parasitic hydroperoxide metabolism
Flohé, L., Hecht, H. J., & Steinert, P. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00172-0 · Cited by 211
In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs
Seifert, K., & Croft, S. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.73-79.2006 · Cited by 207
Grondin, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3057 · Cited by 188
Deficient metabolic utilization of hydrogen peroxide in Trypanosoma cruzi
Boveris, A., Sies, H., Martino, E. E., Docampo, R., Turrens, J. F., & Stoppani, A. O. (1980) · Biochemical Journal · doi:10.1042/bj1880643 · Cited by 186
Amphotericin B and Its New Derivatives – Mode of Action
Baginski, M., & Czub, J. (2009) · Current Drug Metabolism · doi:10.2174/138920009788898019 · Cited by 173
Potential Basis for Amphotericin B Resistance in Aspergillus terreus
Blum, G., Perkhofer, S., Haas, H., Schrettl, M., Würzner, R., Dierich, M. P., & Lass‐Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01280-07 · Cited by 161
Henderson, D. M., Sifri, C. D., Rodgers, M., Wirth, D. F., Hendrickson, N., & Ullman, B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2855 · Cited by 159
Sterols of Leishmania species, implications for biosynthesis
Goad, L. J., Holz, G. G., & Beach, D. H. (1984) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(84)90004-5 · Cited by 117
Amphotericin B: delivery systems
Brajtburg, J., Powderly, W. G., Kobayashi, G. S., & Medoff, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.3.381 · Cited by 117
Sokol-Anderson, M., Sligh, J. E., Elberg, S., Brajtburg, J., Kobayashi, G. S., & Medoff, G. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.702 · Cited by 113
Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania
Moreira, W., Leprohon, P., & Ouellette, M. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.83 · Cited by 112
Pourshafie, M. R., Morand, S. C., Virion, A., Rakotomanga, M., Dupuy, C., & Loiseau, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2409-2414.2004 · Cited by 85
ABC transporters in Leishmania and their role in drug resistance
Ouellette, M., Légaré, D., Haimeur, A., Grondin, K., Roy, G., Brochu, C., & Papadopoulou, B. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80213-6 · Cited by 83
Lamp-Freund, M. T., Ferreira, V. F. N., & Schreier, S. (1985) · Journal of antibiotics (Tokyo. 1968) · doi:10.7164/antibiotics.38.753 · Cited by 76
Cai, C., Hua Zhu, C., & Chen, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.030 · Cited by 52
Involvement of thiol metabolism in resistance to glucantime in leishmania tropica
Arana, F. E., Pérez-Victoria, J. M., Repetto, Y., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00129-4 · Cited by 36
Spin-labeled amphotericin B: synthesis, characterization, biological and spectroscopic properties
Urbina, J. A., Cohen, B. E., Perozo, E., & Cornivelli, L. (1987) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(87)90443-3 · Cited by 19
Cited by
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M. P., López-Vélez, R., García-Hernández, R., Pountain, A. W., Mwenechanya, R., & Papadopoulou, B. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006052 · Cited by 962
Leishmaniasis in humans: drug or vaccine therapy?
Ghorbani, M., & Farhoudi, R. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s146521 · Cited by 355
Chemotherapy of leishmaniasis: present challenges
ULIANA, S. R. B., TRINCONI, C. T., & COELHO, A. C. (2018) · Parasitology · doi:10.1017/s0031182016002523 · Cited by 261
Echinocandins in antifungal pharmacotherapy
Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145
Metadata
- Authors
- Purkait, B., Kumar, A., Nandi, N., Sardar, A. H., Das, S., Kumar, S., Pandey, K., Ravidas, V., Kumar, M., De, T., Singh, D., & Das, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-02
- Volume
- 56
- Issue
- 2
- Pages
- 1031-1041
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1985704586
- Cited by
- 324
- References
- 36
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.